P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Detalles Bibliográficos
Autores principales: Kalac, Matko, Hertzberg, Mark, Cheah, Chan, Ribrag, Vincent, Abrisquet Acosta, Pablo, Opat, Stephen, Bachy, Emmanuel, Ysebaert, Loïc, Qiu, Lihua, Yi, Shuhua, Nishimura, Noriko, Lemech, Charlotte, Bussolari, Jacqueline, Deng, Changchun, Lu, Tianbao, Xiu, Liang, Van Hemelryck, Sandy, Philippar, Ulrike, Guo, Yue, Soete, Virginie, Soriano, Isabel, Fourneau, Nele, Gerecitano, John, Morschhauser, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429444/
http://dx.doi.org/10.1097/01.HS9.0000969400.60782.b9

Ejemplares similares

Ejemplares similares